Overview
Mark Hamblin is a Pulmonary Medicine provider in Kansas City, Kansas. Dr. Hamblin is rated as an Experienced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Sarcoidosis, and Bone Marrow Aspiration. Dr. Hamblin is currently accepting new patients.
His clinical research consists of co-authoring 15 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4000 Cambridge St, Kansas City, KS 66160
3901 Rainbow Blvd, Suite 5300, Kansas City, KS 66160
12000 W 110th St, Overland Park, KS 66210
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Kansas University Physicians Inc
Heath Latham is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Kansas City, Kansas. Dr. Latham is rated as an Advanced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Lung Metastases, Alpha-1 Antitrypsin Deficiency (AATD), Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease, and Endoscopy. Dr. Latham is currently accepting new patients.
Saint Lukes Physician Group Inc
Vincent Lem is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Leavenworth, Kansas. Dr. Lem is rated as a Distinguished provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Lung Nodules, Chronic Cough, Lung Metastases, and Diffuse Panbronchiolitis. Dr. Lem is currently accepting new patients.
Inpatient Consultants Of Kansas PA
Jacqueline Smith is a Pulmonary Medicine provider in Shawnee Mission, Kansas. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). Her top areas of expertise are Lung Metastases, Pleural Effusion, Pneumonia, and Chronic Obstructive Pulmonary Disease (COPD).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Interstitial PneumoniaDr. Hamblin isElite. Learn about Acute Interstitial Pneumonia.
- Interstitial Lung DiseaseDr. Hamblin isElite. Learn about Interstitial Lung Disease.
- Distinguished
- Hypersensitivity PneumonitisDr. Hamblin isDistinguished. Learn about Hypersensitivity Pneumonitis.
- Idiopathic Pulmonary FibrosisDr. Hamblin isDistinguished. Learn about Idiopathic Pulmonary Fibrosis.
- Lung MetastasesDr. Hamblin isDistinguished. Learn about Lung Metastases.
- NeurosarcoidosisDr. Hamblin isDistinguished. Learn about Neurosarcoidosis.
- PneumoniaDr. Hamblin isDistinguished. Learn about Pneumonia.
- Pulmonary FibrosisDr. Hamblin isDistinguished. Learn about Pulmonary Fibrosis.
- Advanced
- Bronchogenic CystDr. Hamblin isAdvanced. Learn about Bronchogenic Cyst.
- Cystic FibrosisDr. Hamblin isAdvanced. Learn about Cystic Fibrosis.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- LymphangioleiomyomatosisDr. Hamblin isAdvanced. Learn about Lymphangioleiomyomatosis.
- Lymphofollicular HyperplasiaDr. Hamblin isAdvanced. Learn about Lymphofollicular Hyperplasia.
- Pulmonary HypertensionDr. Hamblin isAdvanced. Learn about Pulmonary Hypertension.
- Experienced
- Alpha-1 Antitrypsin Deficiency (AATD)Dr. Hamblin isExperienced. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- AspergillosisDr. Hamblin isExperienced. Learn about Aspergillosis.
- Birt-Hogg-Dube SyndromeDr. Hamblin isExperienced. Learn about Birt-Hogg-Dube Syndrome.
- Bone Marrow AspirationDr. Hamblin isExperienced. Learn about Bone Marrow Aspiration.
- Branchiootorenal SyndromeDr. Hamblin isExperienced. Learn about Branchiootorenal Syndrome.
- BronchiectasisDr. Hamblin isExperienced. Learn about Bronchiectasis.